LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC

被引:0
作者
Chengcheng Yang
Huangzhen Wang
Boxiang Zhang
Yimeng Chen
Yamin Zhang
Xin Sun
Guodong Xiao
Kejun Nan
Hong Ren
Sida Qin
机构
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department Two of Thoracic Surgery
[2] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Oncology
[3] Department of Surgical Oncology,undefined
[4] Baoji Central Hospital,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 35卷
关键词
NSCLC; cIAP; LCL161; Paclitaxel; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 183 条
[1]  
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]  
Bray F(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
[3]  
Siegel RL(2005)Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline Lung Cancer 50 355-74
[4]  
Ferlay J(2009)Targeting the ubiquitin system in cancer therapy Nature 458 438-44
[5]  
Lortet-Tieulent J(2011)Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death Nat Rev Mol Cell Biol 12 439-52
[6]  
Jemal A(2012)The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling Nat Rev Immunol 12 833-44
[7]  
Siegel RL(2013)Antagonists of IAP proteins as cancer therapeutics Cancer Lett 332 206-14
[8]  
Miller KD(2012)Targeting IAP proteins for therapeutic intervention in cancer Nat Rev Drug Discov 11 109-24
[9]  
Jemal A(2014)Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis Cancer Lett 344 101-9
[10]  
Chu Q(2013)Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer Cancer Lett 329 118-24